Cost-utility analysis of nanoparticle albumin-bound paclitaxel versus paclitaxel in monotherapy in pretreated metastatic breast cancer in Spain

dc.contributor.author	López López, Rafael
dc.date.accessioned	2017-06-07T07:05:14Z
dc.date.available	2017-06-07T07:05:14Z
dc.date.issued	2013
dc.identifier.issn	1473-7167
dc.identifier.uri	http://hdl.handle.net/20.500.11940/2414
dc.language.iso	eng
dc.title	Cost-utility analysis of nanoparticle albumin-bound paclitaxel versus paclitaxel in monotherapy in pretreated metastatic breast cancer in Spain
dc.type	Artigo	es
dc.authorsophos	Alba, E.
dc.authorsophos	Ciruelos, E.
dc.authorsophos	López, R.
dc.authorsophos	López-Vega, J. M.
dc.authorsophos	Lluch, A.
dc.authorsophos	Martín, M.
dc.authorsophos	Muñoz, M.
dc.authorsophos	Sánchez-Rovira, P.
dc.authorsophos	Seguí, M. Á
dc.authorsophos	Liria, M. R.
dc.authorsophos	Pérez-Alcántara, F.
dc.identifier.doi	10.1586/erp.13.18
dc.identifier.isi	320378200016
dc.identifier.pmid	23534988
dc.identifier.sophos	13150
dc.issue.number	3
dc.journal.title	Expert review of pharmacoeconomics & outcomes research
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Oncoloxía médica
dc.page.initial	381
dc.page.final	391
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	13

Files in this item

Files	Size	Format	View
There are no files associated with this item.